Skip to main content

Duquesne Family Office LLC

Family Office

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 1536411 New York, NY

Position in NAMS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$104,047,247
+$5,771,874 QoQ
Shares Held
3,070,146
0.0% QoQ
Ownership
2.57%
of shares outstanding
% of Portfolio
2.48%
of 13F equity value
Holder Rank
#10
of 197 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NAMS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Duquesne Family Office LLC holds $548,000,096 across 17 Biotechnology names. NAMS ranks #2 (19.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NAMS
NewAmsterdam Pharma Co N.V.
This page
3,070,146 $104,047,247

All Filings in NAMS

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $104,047,247 3,070,146
2026-03-31 $98,275,373 3,070,146
2025-12-31 $107,700,721 3,070,146
2025-09-30 $54,710,028 1,923,700
2025-06-30 $15,070,689 832,175
2025-03-31 $16,383,369 800,360
2024-12-31 $7,389,649 287,535
2024-09-30 $4,773,081 287,535